VP and Chief Scientist Officer in NeuroNova AB
Dr Haegerstrand joined NeuroNova in 2000. In addition to the general responsibilites as CSO, Dr Haegerstrand has been responsible for the preclinical development and initial clinical study plans for NeuroNova’s projects heading for clinical trials during 2007-2008. Dr Haegerstrand was formerly Global Manager of the discovery research portfolio and external collaborations within CNS and Pain Control Discovery at AstraZeneca plc (1999-2000). Prior to this, Dr Haegerstrand was Project Manager (1995-1997) and Vice President of Discovery Research (1996-1999) at the former company Astra Pain Control AB. Dr Haegerstrand co-managed product development of encapsulated cell therapy, including FDA regulated clinical phase I/II trials.
- No related content found